Oncolytic measles virus as a novel therapy for malignant peripheral nerve sheath tumors

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Malignant peripheral nerve sheath tumors (MPNSTs) are devastating soft tissue sarcomas that can arise sporadically or in association with neurofibromatosis type I, have a poor prognosis, and have limited treatment options. Oncolytic measles virus therapy has been demonstrated to have significant antitumor properties in a number of different cancers, but the oncolytic potential of a MV Edmonston (MVEdm) vaccine strain engineered to express the human sodium iodide symporter (MV-NIS) on MPNST has not previously been evaluated. MPNST cell lines were found to highly express CD46, a cellular receptor required for measles viral entry, on their cell surface. After in vitro MV-NIS infection, MPNST cell lines showed significant cytopathic effect (CPE), while normal Schwann cells were less susceptible to CPE. Virus localization and distribution could be monitored by imaging of I-125 uptake. Local administration of MV-NIS into MPNST-derived tumors resulted in significant regression of tumor and improved survival. These results demonstrate feasibility of oncolytic measles virus therapy for MPNST patients and the possibility of a novel treatment for patients with NF1 tumors.

Original languageEnglish (US)
Pages (from-to)140-145
Number of pages6
JournalGene
Volume565
Issue number1
DOIs
StatePublished - Jul 1 2015

Fingerprint

Oncolytic Viruses
Measles virus
Neurilemmoma
Oncolytic Virotherapy
Tumor Cell Line
Neoplasms
Therapeutics
Neurofibromatosis 1
Schwann Cells
Measles
Sarcoma
Vaccines
Viruses
Survival
Infection

Keywords

  • Malignant peripheral nerve sheath tumor
  • Measles virus
  • Oncolytic therapy

ASJC Scopus subject areas

  • Genetics

Cite this

Oncolytic measles virus as a novel therapy for malignant peripheral nerve sheath tumors. / Deyle, David R; Escobar, Diana Zarate; Peng, Kah-Whye; Babovic-Vuksanovic, Dusica.

In: Gene, Vol. 565, No. 1, 01.07.2015, p. 140-145.

Research output: Contribution to journalArticle

@article{141cf8cd6a9641ffb854df4c339ddf7a,
title = "Oncolytic measles virus as a novel therapy for malignant peripheral nerve sheath tumors",
abstract = "Malignant peripheral nerve sheath tumors (MPNSTs) are devastating soft tissue sarcomas that can arise sporadically or in association with neurofibromatosis type I, have a poor prognosis, and have limited treatment options. Oncolytic measles virus therapy has been demonstrated to have significant antitumor properties in a number of different cancers, but the oncolytic potential of a MV Edmonston (MVEdm) vaccine strain engineered to express the human sodium iodide symporter (MV-NIS) on MPNST has not previously been evaluated. MPNST cell lines were found to highly express CD46, a cellular receptor required for measles viral entry, on their cell surface. After in vitro MV-NIS infection, MPNST cell lines showed significant cytopathic effect (CPE), while normal Schwann cells were less susceptible to CPE. Virus localization and distribution could be monitored by imaging of I-125 uptake. Local administration of MV-NIS into MPNST-derived tumors resulted in significant regression of tumor and improved survival. These results demonstrate feasibility of oncolytic measles virus therapy for MPNST patients and the possibility of a novel treatment for patients with NF1 tumors.",
keywords = "Malignant peripheral nerve sheath tumor, Measles virus, Oncolytic therapy",
author = "Deyle, {David R} and Escobar, {Diana Zarate} and Kah-Whye Peng and Dusica Babovic-Vuksanovic",
year = "2015",
month = "7",
day = "1",
doi = "10.1016/j.gene.2015.04.001",
language = "English (US)",
volume = "565",
pages = "140--145",
journal = "Gene",
issn = "0378-1119",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Oncolytic measles virus as a novel therapy for malignant peripheral nerve sheath tumors

AU - Deyle, David R

AU - Escobar, Diana Zarate

AU - Peng, Kah-Whye

AU - Babovic-Vuksanovic, Dusica

PY - 2015/7/1

Y1 - 2015/7/1

N2 - Malignant peripheral nerve sheath tumors (MPNSTs) are devastating soft tissue sarcomas that can arise sporadically or in association with neurofibromatosis type I, have a poor prognosis, and have limited treatment options. Oncolytic measles virus therapy has been demonstrated to have significant antitumor properties in a number of different cancers, but the oncolytic potential of a MV Edmonston (MVEdm) vaccine strain engineered to express the human sodium iodide symporter (MV-NIS) on MPNST has not previously been evaluated. MPNST cell lines were found to highly express CD46, a cellular receptor required for measles viral entry, on their cell surface. After in vitro MV-NIS infection, MPNST cell lines showed significant cytopathic effect (CPE), while normal Schwann cells were less susceptible to CPE. Virus localization and distribution could be monitored by imaging of I-125 uptake. Local administration of MV-NIS into MPNST-derived tumors resulted in significant regression of tumor and improved survival. These results demonstrate feasibility of oncolytic measles virus therapy for MPNST patients and the possibility of a novel treatment for patients with NF1 tumors.

AB - Malignant peripheral nerve sheath tumors (MPNSTs) are devastating soft tissue sarcomas that can arise sporadically or in association with neurofibromatosis type I, have a poor prognosis, and have limited treatment options. Oncolytic measles virus therapy has been demonstrated to have significant antitumor properties in a number of different cancers, but the oncolytic potential of a MV Edmonston (MVEdm) vaccine strain engineered to express the human sodium iodide symporter (MV-NIS) on MPNST has not previously been evaluated. MPNST cell lines were found to highly express CD46, a cellular receptor required for measles viral entry, on their cell surface. After in vitro MV-NIS infection, MPNST cell lines showed significant cytopathic effect (CPE), while normal Schwann cells were less susceptible to CPE. Virus localization and distribution could be monitored by imaging of I-125 uptake. Local administration of MV-NIS into MPNST-derived tumors resulted in significant regression of tumor and improved survival. These results demonstrate feasibility of oncolytic measles virus therapy for MPNST patients and the possibility of a novel treatment for patients with NF1 tumors.

KW - Malignant peripheral nerve sheath tumor

KW - Measles virus

KW - Oncolytic therapy

UR - http://www.scopus.com/inward/record.url?scp=84928431742&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928431742&partnerID=8YFLogxK

U2 - 10.1016/j.gene.2015.04.001

DO - 10.1016/j.gene.2015.04.001

M3 - Article

C2 - 25843626

AN - SCOPUS:84928431742

VL - 565

SP - 140

EP - 145

JO - Gene

JF - Gene

SN - 0378-1119

IS - 1

ER -